Noteborn HP - Search Results

1

The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo.

Van Schooten FJ, Kriek E, Steenwinkel MJ, Noteborn HP, Hillebrand MJ, Van Leeuwen FE. Van Schooten FJ, et al. Among authors: noteborn hp. Carcinogenesis. 1987 Sep;8(9):1263-9. doi: 10.1093/carcin/8.9.1263. Carcinogenesis. 1987. PMID: 3113753

2

Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein.

Gee JM, Noteborn HP, Polley AC, Johnson IT. Gee JM, et al. Among authors: noteborn hp. Carcinogenesis. 2000 Dec;21(12):2255-9. doi: 10.1093/carcin/21.12.2255. Carcinogenesis. 2000. PMID: 11133815

3

Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats.

Steensma A, Faassen-Peters MA, Noteborn HP, Rietjens IM. Steensma A, et al. Among authors: noteborn hp. J Agric Food Chem. 2006 Oct 18;54(21):8006-12. doi: 10.1021/jf060783t. J Agric Food Chem. 2006. PMID: 17032002

4

Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides.

Steensma A, Noteborn HP, Kuiper HA. Steensma A, et al. Among authors: noteborn hp. Environ Toxicol Pharmacol. 2004 Apr;16(3):131-9. doi: 10.1016/j.etap.2003.11.008. Environ Toxicol Pharmacol. 2004. PMID: 21782699

5

Intestinal uptake of genistein and its glycoside in the rat using various isolated perfused gut segments.

Steensma A, Bienenmann-Ploum ME, Noteborn HP. Steensma A, et al. Among authors: noteborn hp. Environ Toxicol Pharmacol. 2004 Jun;17(2):103-10. doi: 10.1016/j.etap.2004.03.008. Environ Toxicol Pharmacol. 2004. PMID: 21782720

6

Bioavailability of genistein, daidzein, and their glycosides in intestinal epithelial Caco-2 cells.

Steensma A, Noteborn HP, Jagt RC, Polman TH, Mengelers MJ, Kuiper HA. Steensma A, et al. Among authors: noteborn hp. Environ Toxicol Pharmacol. 1999 Jul;7(3):209-12. doi: 10.1016/s1382-6689(99)00015-0. Environ Toxicol Pharmacol. 1999. PMID: 21781927

7

Substantial equivalence--an appropriate paradigm for the safety assessment of genetically modified foods?

Kuiper HA, Kleter GA, Noteborn HP, Kok EJ. Kuiper HA, et al. Among authors: noteborn hp. Toxicology. 2002 Dec 27;181-182:427-31. doi: 10.1016/s0300-483x(02)00488-2. Toxicology. 2002. PMID: 12505347 Review.

8

Adequacy of methods for testing the safety of genetically modified foods.

Kuiper HA, Noteborn HP, Peijnenburg AA. Kuiper HA, et al. Among authors: noteborn hp. Lancet. 1999 Oct 16;354(9187):1315-6. doi: 10.1016/S0140-6736(99)00341-4. Lancet. 1999. PMID: 10533854 No abstract available.

9

Assessment of the food safety issues related to genetically modified foods.

Kuiper HA, Kleter GA, Noteborn HP, Kok EJ. Kuiper HA, et al. Among authors: noteborn hp. Plant J. 2001 Sep;27(6):503-28. doi: 10.1046/j.1365-313x.2001.01119.x. Plant J. 2001. PMID: 11576435 Free article. Review.

10

Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems.

Noteborn HP, Jansen E, Benito S, Mengelers MJ. Noteborn HP, et al. Cancer Lett. 1997 Mar 19;114(1-2):175-7. doi: 10.1016/s0304-3835(97)04655-7. Cancer Lett. 1997. PMID: 9103284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters